— Know what they know.
Not Investment Advice
Also trades as: 0K05.L (LSE) · $vol 0M

MED NYSE

Medifast, Inc.
1W: +0.6% 1M: +15.6% 3M: +19.1% YTD: +21.7% 1Y: -9.2% 3Y: -85.3% 5Y: -95.2%
$12.59
-0.04 (-0.32%)
 
Weekly Expected Move ±11.8%
$10 $11 $13 $14 $15
NYSE · Consumer Cyclical · Personal Products & Services · Alpha Radar Strong Buy · Power 68 · $140.0M mcap · 8M float · 2.83% daily turnover · Short 62% of daily vol
0.00
Neutral
0 bullish 0 neutral 0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
2 bullish 0 neutral 0 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (50)
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do
Bullish GlobeNewsWire-FDA · 1d ago · 0.90
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes
Bullish GlobeNewsWire-FDA · 1d ago · 0.90
Peer-Reviewed Research Is Redefining Weight Loss Program Standards
GlobeNewsWire-FDA · 1w ago · 0.00
Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation
Bullish GlobeNewsWire-FDA · 1w ago · 0.90
3 Highly Ranked Medical Stocks to Buy Now: DVA, GMED, PGNY
Bullish Zacks · 1w ago · 0.90
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
Bullish Zacks · 2w ago · 0.90
Why is Medifast stock surging despite weak Q1? $30M cost-cut plan
Bullish SeekingAlpha · 2w ago · 0.90
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care
Bullish Zacks · 2w ago · 0.90
Medifast reconfirms $270M-$300M 2026 revenue outlook as it targets profitability improvements starting in Q4 2026
Bullish SeekingAlpha · 2w ago · 0.90
Medifast (MED) Q1 2026 Earnings Transcript
MotleyFool · 2w ago · 0.00
Medifast (MED) Reports Q1 Loss, Tops Revenue Estimates
Bullish Zacks · 2w ago · 0.90
Medifast GAAP EPS of -$0.19 beats by $0.33, revenue of $76M beats by $6.8M
Bullish SeekingAlpha · 2w ago · 0.90
Here are the major earnings after the close Monday
SeekingAlpha · 2w ago · 0.00
Earnings Scheduled For May 4, 2026
Bearish Benzinga-Earnings · 2w ago · -0.90
Medifast Q1 2026 Earnings Preview
SeekingAlpha · 2w ago · 0.00
Medifast's Q1 Earnings on The Horizon: Key Insights for Investors
Bearish Zacks · 3w ago · -0.90
12 Consumer Staples Stocks Moving In Wednesday's After-Market Session
Bullish Benzinga-Movers · 3w ago · 0.90
Medifast's New Product Pipeline: Key Catalyst for Comeback?
Zacks · 6w ago · 0.00
Hims & Hers Advances a Consumer-Centric Digital Health Platform
Bullish Zacks · 6w ago · 0.90
Newell Strengthens Capabilities and Innovation to Power Growth
Bullish Zacks · 8w ago · 0.90
Clorox Leverages Digital and Operational Optimization to Aid Growth
Bullish Zacks · 8w ago · 0.90
AB InBev Leverages Premiumization and Digital Expansion to Fuel Growth
Bullish Zacks · 8w ago · 0.90
Will Archer Daniels' Strategic Moves & Cost Savings Aid Growth?
Bullish Zacks · 9w ago · 0.90
Medifast (MED) Down 5.7% Since Last Earnings Report: Can It Rebound?
Bearish Zacks · 9w ago · -0.90
Brown-Forman Drives Growth Through Brand Strength and Premiumization
Bullish Zacks · 9w ago · 0.90
Ollie's Bargain Q4 Earnings Beat Estimates, Comps Rise 3.6% Y/Y
Bullish Zacks · 10w ago · 0.90
Is Constellation Brands' Focus on Core Brands the Key to Success?
Bullish Zacks · 10w ago · 0.90
Newell's Productivity Plan & Other Strategies to Bolster Growth
Bullish Zacks · 10w ago · 0.90
Hims and Hers Expands Consumer-Focused Digital Health Platform
Bullish Zacks · 10w ago · 0.90
Is Clorox's International Expansion Key to Its Long-Term Success?
Bullish Zacks · 11w ago · 0.90
Brown-Forman's Q3 Earnings Beat Mark, Organic Sales Rise 1% Y/Y
Bullish Zacks · 11w ago · 0.90
Monster Beverage's Stock Falls 9% Post Q4 Earnings: What to Know?
Bearish Zacks · 11w ago · -0.90
Can Post Holdings Sustain Growth on Foodservice Strength?
Bullish Zacks · 11w ago · 0.90
Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
Bullish BusinessWire · 13w ago · 0.90
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
BusinessWire · 13w ago · 0.00
Medifast's Q4 Earnings on Deck: What Could Shape MED's Results?
Bearish Zacks · 14w ago · -0.90
Analysts Estimate Medifast (MED) to Report a Decline in Earnings: What to Look Out for
Bearish Zacks · 14w ago · -0.90
Medifast (MED) to Release Earnings on Tuesday
Bearish DefenseWorld · 14w ago · -0.90
Medifast Is A Net-Net With Negative Enterprise Value
Bearish SeekingAlpha · 15w ago · -0.90
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025
BusinessWire · 15w ago · 0.00
Medifast's Q4 Guidance Remains Weak: When Does Growth Return?
Bearish Zacks · 17w ago · -0.90
People Magazine Spotlights Tiffany Howard's Metabolic Health Journey with OPTAVIA®
BusinessWire · 18w ago · 0.00
OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity
BusinessWire · 18w ago · 0.00
Medifast Shifts to Metabolic Health: A Durable Growth Path?
Bullish Zacks · 19w ago · 0.90
Medifast Announces Planned Leadership Transition
BusinessWire · 19w ago · 0.00
Medifast New Product Line Planned: Can Innovation Reignite Demand?
Zacks · 20w ago · 0.00
Medifast's Third-Quarter Revenue Fell 36%: Is Stabilization Near?
Bearish Zacks · 21w ago · -0.90
Can Medifast Overcome GLP-1 Pressure With Its Growth Strategy?
Zacks · 22w ago · 0.00
OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing
Bullish BusinessWire · 23w ago · 0.90
Medifast (NYSE:MED) and BAB (OTCMKTS:BABB) Financial Survey
DefenseWorld · 23w ago · 0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms